{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:31:42Z","timestamp":1790667102511,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.xphs.2015.11.045","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T06:30:53Z","timestamp":1454394653000},"page":"2703-2711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cyclodextrin and Meglumine-Based Microemulsions as a Poorly Water-Soluble Drug Delivery System"],"prefix":"10.1016","volume":"105","author":[{"given":"Carolina","family":"Aloisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselmo","family":"G. de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2008","key":"10.1016\/j.xphs.2015.11.045_bib1","first-page":"351","article-title":"Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides","volume":"350","author":"Graf","year":"2007","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2015.11.045_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1248\/cpb.59.172","article-title":"Development and characterization of eucalyptol microemulsions for topic delivery of curcumin","volume":"59","author":"Iu","year":"2011","journal-title":"Chem Pharm Bull"},{"issue":"1-2","key":"10.1016\/j.xphs.2015.11.045_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2007.10.041","article-title":"The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic\/capric glycerides","volume":"352","author":"Djekic","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2006.05.019","article-title":"Physicochemical characterization and evaluation of a microemulsion system for antimicrobial activity of glycerol monolaurate","volume":"321","author":"Fu","year":"2006","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2015.11.045_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2005.09.006","article-title":"Studies on the stability of the chloramphenicol in the microemulsion free of alcohols","volume":"62","author":"Lv","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib6","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1002\/jps.24555","article-title":"Development and characterization of a biocompatible soybean oil-based microemulsion for the delivery of poorly water-soluble drugs","volume":"104","author":"Aloisio","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2015.11.045_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2012.01.019","article-title":"Preparation of high solubilizable microemulsion of naproxen and its solubilization mechanism","volume":"426","author":"Tian","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib8","first-page":"185","article-title":"Solubilization of azithromycin in microemulsions based on mixed nonionic surfactants and mixed oils solubilization of azithromycin in microemulsions based on mixed nonionic surfactants and mixed oils","volume":"33","author":"Taylor","year":"2012","journal-title":"J\u00a0Disper Sci Technol"},{"key":"10.1016\/j.xphs.2015.11.045_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12249-009-9356-5","article-title":"Tween-embedded microemulsions\u2014physicochemical and spectroscopic analysis for antitubercular drugs","volume":"11","author":"Mehta","year":"2009","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.xphs.2015.11.045_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2005.04.013","article-title":"Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization","volume":"106","author":"Krauel","year":"2005","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2015.11.045_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5173(99)00099-X","article-title":"Inclusion complex of piroxicam with \u00df-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion","volume":"184","author":"Dalmora","year":"1999","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2015.11.045_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2008.12.028","article-title":"Innovative formulations for the delivery of levothyroxine to the skin","volume":"372","author":"Padula","year":"2009","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.09.014","article-title":"Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: Ketoprofen, lidocaine, and caffeine","volume":"421","author":"Zhang","year":"2011","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2015.11.045_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2012.01.011","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of a simple microemulsion formulation for propofol","volume":"425","author":"Li","year":"2012","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2015.11.045_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejps.2010.03.008","article-title":"Microemulsion formulations for the transdermal delivery of testosterone","volume":"40","author":"Hathout","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2015.11.045_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.farmac.2004.05.009","article-title":"NMR spectroscopy of inclusion complex of D-(-)-chloramphenicol with \u00df-cyclodextrin in aqueous solution","volume":"59","author":"Ali","year":"2004","journal-title":"Farmaco"},{"key":"10.1016\/j.xphs.2015.11.045_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2009.06.005","article-title":"CDs as solubilizers: effects of excipients and competing drugs","volume":"379","author":"Jansook","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib18","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1016\/j.bmc.2009.07.060","article-title":"Artemether\/hydroxypropyl-\u03b2-cyclodextrin host\u2013guest system: characterization, phase-solubility and inclusion mode","volume":"17","author":"Yang","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"2008","key":"10.1016\/j.xphs.2015.11.045_bib19","first-page":"70","article-title":"Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-\u00df-cyclodextrin solution","volume":"354","author":"Iohara","year":"2007","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2015.11.045_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3109\/03639045.2013.790408","article-title":"Characterization, inclusion mode, phase-solubility and in\u00a0vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug","volume":"40","author":"Aloisio","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"issue":"2-3","key":"10.1016\/j.xphs.2015.11.045_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2008.02.007","article-title":"Comparative interaction of 2-hydroxypropyl-\u03b2-cyclodextrin and sulfobutylether-\u03b2-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions","volume":"34","author":"Brewster","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2015.11.045_bib22","first-page":"220","article-title":"Studies on the preparation, characterization, and solubility of 2-HP-\u03b2-cyclodextrin-meclizine HCI inclusion complexes","volume":"4","author":"George","year":"2012","journal-title":"J\u00a0Young Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2015.11.045_bib23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bmcl.2010.11.073","article-title":"Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by \u03b2-cyclodextrin","volume":"21","author":"Mishur","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.xphs.2015.11.045_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpba.2007.07.030","article-title":"Study of ascorbic acid interaction with hydroxypropyl-\u00df-cyclodextrin and triethanolamine, separately and in combination","volume":"45","author":"Garnero","year":"2007","journal-title":"J\u00a0Pharm Biomed"},{"issue":"4","key":"10.1016\/j.xphs.2015.11.045_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpba.2007.11.037","article-title":"Non-covalent inclusion of ferulic acid with \u03b1-cyclodextrin improves photo-stability and delivery: NMR and modeling studies","volume":"46","author":"Anselmi","year":"2008","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2015.11.045_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpba.2012.04.038","article-title":"Alpinetin\/hydroxypropyl-\u03b2-cyclodextrin host\u2013guest system: preparation, characterization, inclusion mode, solubilization and stability","volume":"67-68","author":"Ma","year":"2012","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"2","key":"10.1016\/j.xphs.2015.11.045_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2009.11.003","article-title":"Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity","volume":"74","author":"Swaminathan","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpba.2013.05.001","article-title":"Ternary system of dihydroartemisinin with hydroxypropyl-\u03b2-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions","volume":"83","author":"Wang","year":"2013","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2015.11.045_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpba.2014.07.008","article-title":"Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine","volume":"100","author":"Aloisio","year":"2014","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2015.11.045_bib30","series-title":"Guidance for Industry Guidance for Industry Waiver of In\u00a0Vivo Bioavailability and Bioequivalence Studies for Immediate Release Dosage Forms Based on a Biopharmaceutical Classification System","year":"2000"},{"key":"10.1016\/j.xphs.2015.11.045_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-3659(99)00022-X","article-title":"Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems","volume":"62","author":"Lipka","year":"1999","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2015.11.045_bib32","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/mp300140h","article-title":"The fraction dose absorbed, in humans, and high jejunal human permeability relationship","volume":"9","author":"Dahan","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2014.01.009","article-title":"The Biopharmaceutics Classification System: subclasses for in\u00a0vivo predictive dissolution (IPD) methodology and IVIVC","volume":"16","author":"Tsume","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"2007","key":"10.1016\/j.xphs.2015.11.045_bib34","first-page":"1","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2006","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2015.11.045_bib35","first-page":"830","article-title":"Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility","volume":"60","author":"Gupta","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.xphs.2015.11.045_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2007.06.029","article-title":"Enhanced oral delivery of antimony from meglumine antimoniate\/\u00df-cyclodextrin nanoassemblies","volume":"347","author":"Fr\u00e9zard","year":"2008","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2015.11.045_bib37","first-page":"346","article-title":"Modeling of drug release from celecoxib-PVP-meglumine amorphous system","volume":"59","author":"Gupta","year":"2005","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2015.11.045_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1211\/0022357055597","article-title":"Molecular interactions in celecoxib-PVP-meglumine amorphous system","volume":"57","author":"Gupta","year":"2005","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2004.03.010","article-title":"In\u00a0vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components","volume":"58","author":"Richter","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2015.11.045_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2005.02.014","article-title":"In\u00a0vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions","volume":"296","author":"Djordjevic","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2015.11.045_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.powtec.2012.07.004","article-title":"Dissolution enhancement of indomethacin via amorphization using co-milling and supercritical co-precipitation processing","volume":"240","author":"Lim","year":"2013","journal-title":"Powder Technol"},{"key":"10.1016\/j.xphs.2015.11.045_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2014.10.019","article-title":"Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs","volume":"67","author":"Khadra","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(00)00334-3","article-title":"Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system","volume":"200","author":"Lentz","year":"2000","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.colsurfb.2006.05.005","article-title":"Doxorubicin biocompatible O\/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine","volume":"51","author":"Formariz","year":"2006","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"10.1016\/j.xphs.2015.11.045_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jconrel.2011.06.034","article-title":"A\u00a0delivery system to avoid self-aggregation and to improve in\u00a0vitro and in\u00a0vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy","volume":"155","author":"F\u00e1bia","year":"2011","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(97)00248-2","article-title":"Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides","volume":"158","author":"Constantinides","year":"1997","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2015.11.045_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(98)00361-5","article-title":"Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in\u00a0vitro and in\u00a0vivo studies","volume":"178","author":"Fang","year":"1999","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2015.11.045_bib48","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1023\/A:1016280714593","article-title":"Apparent pKa of the fatty acids within ordered mixtures of model human stratum corneum lipids","volume":"12","author":"Lieckfeldt","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2015.11.045_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2007.04.029","article-title":"Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins","volume":"342","author":"Brewster","year":"2007","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T22:28:17Z","timestamp":1530829697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022354915002014"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2015.11.045","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclodextrin and Meglumine-Based Microemulsions as a Poorly Water-Soluble Drug Delivery System","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2015.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}